<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical, histologic, and cytogenetic features in 63 patients with a therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (t-ANLL) following cytotoxic chemotherapy or radiotherapy for a previous disease were analyzed </plain></SENT>
<SENT sid="1" pm="."><plain>Eleven patients had received only radiotherapy for the primary disorder </plain></SENT>
<SENT sid="2" pm="."><plain>In most cases, high doses had been administered to treatment ports that included the pelvic or spinal bone marrow </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-one patients had received only chemotherapy for their <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e>, <z:hpo ids='HP_0000001'>all</z:hpo> for more than 1 year and <z:hpo ids='HP_0000001'>all</z:hpo> but one with an <z:chebi fb="0" ids="22333">alkylating agent</z:chebi>, either alone or in combination with other drugs </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-one patients had received both radiotherapy and chemotherapy, either concurrently or sequentially </plain></SENT>
<SENT sid="5" pm="."><plain>A clonal chromosomal abnormality was observed in marrow or blood cells from 61 of the 63 patients (97%) </plain></SENT>
<SENT sid="6" pm="."><plain>Fifty-five patients (87%) had a clonal abnormality of chromosomes no. 5 and/or 7 consisting of loss of <z:hpo ids='HP_0000001'>all</z:hpo> or part of the long arm of the chromosome </plain></SENT>
<SENT sid="7" pm="."><plain>The critical chromosome region that was consistently deleted in <z:hpo ids='HP_0000001'>all</z:hpo> 17 patients with del(5q) comprised bands q23 to q32 </plain></SENT>
<SENT sid="8" pm="."><plain>In addition to nos </plain></SENT>
<SENT sid="9" pm="."><plain>5 and 7, five other chromosomes (no. 1, 4, 12, 14, and 18) were found to be nonrandomly involved </plain></SENT>
<SENT sid="10" pm="."><plain>Both t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and t-ANLL are late complications of cytotoxic therapies that have distinctive clinical and histologic features and are associated with characteristic aberrations of chromosomes no. 5 and 7 </plain></SENT>
<SENT sid="11" pm="."><plain>It seems likely that these two chromosomes contain genes involved in the pathogenesis of these hematopoietic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>